phosphoserine has been researched along with Recrudescence in 1 studies
Phosphoserine: The phosphoric acid ester of serine.
The return of a sign, symptom, or disease after a remission.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, H | 1 |
| Nishio, M | 1 |
| Kobayashi, S | 1 |
| Ando, Y | 1 |
| Sugiura, H | 1 |
| Zhang, Z | 1 |
| Hamaguchi, M | 1 |
| Mita, K | 1 |
| Fujii, Y | 1 |
| Iwase, H | 1 |
1 other study(ies) available for phosphoserine and Recrudescence
| Article | Year |
|---|---|
Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chlorocebus aethiops; COS Cells; Epidermal Growth Factor; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; Phosphorylation; Phosphoserine; Prognosis; Receptor, ErbB-2; Receptors, Progesterone; Recombinant Proteins; Recurrence; Survival Analysis; Transfection | 2005 |